+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Combination Drug Delivery Approach as an Effective Therapy for Various Diseases

  • Book

  • April 2022
  • Elsevier Science and Technology
  • ID: 5458216

Combination Drug Delivery Approach as an Effective Therapy for Various Diseases explores the use of bioengineering tools in combination drug delivery approaches to control various diseases at different clinical stages of synergistic action, varying mechanisms of action, and during the suppression of drug resistance. The book presents fundamental knowledge on the experiential and experimental aspects of drug combination approaches in order to equip rational applications in preventing the emergence of resistance during the treatment of various diseases. It provides a holistic understanding of the principles behind formation, characterization, applications, regulations, toxicity, challenges and future perspectives of combination drug delivery approaches.

It will be of interest to researchers and advanced graduate students in pharmaceutical science, chemistry, biology and medicine, as well as pharmaceutical companies and scientific organizations.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Section 1: Combination drug delivery approaches against various diseases 1. Drug resistance as challenges to effective therapy 2. Overcoming the challenges of drug resistance through combination drug delivery approach 3. Combination drug delivery approaches for pulmonary diseases 4. Combination drug delivery approaches in ophthalmology 5. Combination drug delivery system to enhance the transdermal drug delivery 6. Combination drug delivery approaches in arthritis rheumatoid and osteoarthritis 7. Combination drug delivery approaches for cardiovascular disease 8. Combination drug delivery approaches for viral infection 9. Combination drug delivery approaches for malaria parasite 10. Combination drug delivery approaches for tuberculosis

Section 2: Combination drug delivery approaches against cancer 11. Combination drug delivery approaches for cancer therapy 12. Prodrug-based drug delivery approaches in cancer combination therapy 13. Combination of anticancer drugs with microRNA therapeutics as cancer therapeutics 14. Cocktail chemotherapy by combination drug delivery systems 15. Nanotechnology-mediated combinational drug delivery approach for cancer therapy 16. Combinational chemotherapy and hyperthermia in cancer treatment

Section 3: Combination drug delivery approaches challenges and future perspectives 17. Premarket review and�postmarket�regulation of combination drug products 18. Challenges associated with nanoparticulate combination drug delivery systems 19. Concluding remarks and future perspective of combination drug delivery systems

Authors

Prashant Kesharwani Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.

Dr. Prashant Kesharwani is working as an assistant professor of pharmaceutics at the School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 20 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also a receipt of several internationally acclaimed awards such as the most prestigious "Ramanujan Fellowship Award� from the Science and Engineering Research Board, Government of India. He actively participates in outreach and scientific dissemination for the service of the wider community.